Who we are?
Ribicon group is an established German-Canadian corporation, with its affiliates in; Germany, Canada, Sweden, and the Middle East.
Ribicon is leading company in the field of Biomarkers and specialized therapeutics, its core therapy areas include; Oncology, Hematology, Cardiology, Dermatology , and Medical Devices.
Core capabilities are: Innovative products portfolio, strong financial position, Management talents with well-Established relations with key stakeholders in the relative markets.
Our Vision
To be one of the leading companies in Biomarkers and specialized therapeutics areas.
To be one of the leading companies in Biomarkers and specialized therapeutics areas.
Our Mission & Values
To market, commercialize and distribute innovative Medicines that help people live enjoyable life.
To conduct, supply and implement best in class Marketing & Sales Excellence Programs that suits today Business Challenges.
To market, commercialize and distribute innovative Medicines that help people live enjoyable life.
To conduct, supply and implement best in class Marketing & Sales Excellence Programs that suits today Business Challenges.
Our Commitment
To our customer, employees, global communities, shareholders, environment and other stakeholders, we operate with effective governance and high standard of ethical behavior.
We seek transparency and dialogue with our stakeholders to improve our understanding of their needs.
We take our commitment to economic, social, and environment sustainability seriously and extend this expectation to our partners & suppliers.
To our customer, employees, global communities, shareholders, environment and other stakeholders, we operate with effective governance and high standard of ethical behavior.
We seek transparency and dialogue with our stakeholders to improve our understanding of their needs.
We take our commitment to economic, social, and environment sustainability seriously and extend this expectation to our partners & suppliers.